comparemela.com

Latest Breaking News On - Keros therapeutics daily - Page 1 : comparemela.com

Keros Therapeutics, Inc (NASDAQ:KROS) Receives $86 00 Consensus Target Price from Brokerages

Keros Therapeutics, Inc (NASDAQ:KROS) Receives $86 00 Consensus Target Price from Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Keros Therapeutics (NASDAQ:KROS) Stock Rating Reaffirmed by HC Wainwright

Keros Therapeutics (NASDAQ:KROS) Stock Rating Reaffirmed by HC Wainwright
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Keros Therapeutics (NASDAQ:KROS) Stock Price Up 7 5%

Keros Therapeutics (NASDAQ:KROS) Stock Price Up 7 5%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Keros Therapeutics, Inc (NASDAQ:KROS) Given Consensus Rating of Buy by Analysts

Keros Therapeutics, Inc (NASDAQ:KROS) Given Consensus Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Keros Therapeutics (KROS) Overweight Rating Reiterated at Piper Sandler

Piper Sandler reissued their overweight rating on shares of Keros Therapeutics (NASDAQ:KROS – Free Report) in a report issued on Wednesday, Benzinga reports. They currently have a $105.00 price objective on the stock. Several other equities research analysts have also issued reports on the stock. Wedbush reaffirmed an outperform rating and issued a $86.00 price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.